FDA Device Intelligence
Home › MEDTOX DIAGNOSTICS, INC. › VERDICT®-II

VERDICT®-II

MEDTOX DIAGNOSTICS, INC. · Model 601640 · UDI-DI 00690286000230

DJCDIODKEDKZDJG Prescription
2
510(k) clearances
3
Adverse events
0
Recalls
53
Facilities

Description

A qualitative one-step immunochromatographic test panel for the detection of Cannabinoids (THC), Opiates, Amphetamines, Cocaine, and Methamphetamine (MAMP), 3,4-Methylenedioxymethamphetamine (MDMA) drugs and/or their metabolites in human urine.

Query this across every FDA database — by API.

Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.

Get your free API keyRead the docs
Data compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.